Recent advances of 3-fucosyllactose in health effects and production.
Arch Microbiol
; 206(9): 378, 2024 Aug 14.
Article
em En
| MEDLINE
| ID: mdl-39143417
ABSTRACT
Human milk oligosaccharides (HMOs) have been recognized as gold standard for infant development. 3-Fucosyllactose (3-FL), being one of the Generally Recognized as Safe HMOs, represents a core trisaccharide within the realm of HMOs; however, it has received comparatively less attention in contrast to extensively studied 2'-fucosyllactose. The objective of this review is to comprehensively summarize the health effects of 3-FL, including its impact on gut microbiota proliferation, antimicrobial effects, immune regulation, antiviral protection, and brain maturation. Additionally, the discussion also covers the commercial application and regulatory approval status of 3-FL. Lastly, an organized presentation of large-scale production methods for 3-FL aims to provide a comprehensive guide that highlights current strategies and challenges in optimization.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trissacarídeos
/
Microbioma Gastrointestinal
/
Leite Humano
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article